|
|||||
|
|
The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia |
|
| Authors: | Jana Simonds MS IV Frank Miller MD Jess Mandel MD Terence M. Davidson MD |
| Affiliation: | 1. University of California, San Diego School of Medicine, San Diego, California, U.S.A;2. Department of Radiology, University of California, San Diego School of Medicine, San Diego, California, U.S.A.;3. Division of Otolaryngology–Head and Neck Surgery, University of California, San Diego School of Medicine and VA San Diego Healthcare System, San Diego, California, U.S.A |
| Abstract: | |
| Keywords: | Epistaxis hereditary hemorrhagic telangiectasia bevacizumab Avastin |